Ask most people what kind of exercise they should be doing for their long-term health, and the answer almost always involves running, walking, or cycling. Cardiovascular fitness is deeply embedded in health messaging – “get your heart rate up” is advice that has circulated for decades. Strength training, by contrast, is typically framed as a performance goal: something athletes do, or something you pursue if you want to look different. The clinical evidence accumulated over the last decade tells a different and more important story.
In 2022, a systematic review and meta-analysis published in the British Journal of Sports Medicine by Haruki Momma and colleagues at Tohoku University synthesised data from 16 prospective cohort studies examining the health impact of muscle-strengthening activities independently of aerobic exercise. The headline finding: two or more sessions of muscle-strengthening activity per week was associated with a 10-17% lower risk of all-cause mortality – and the cardiovascular disease risk reduction reached 19% in some analyses. A separate dose-response analysis found that approximately 30-60 minutes of strength activity per week captured most of the protective benefit, with a J-shaped curve suggesting that very high volumes provided diminishing returns. These reductions were measured independently of whether participants also did aerobic exercise, meaning the strength-related benefit was not simply a proxy for being generally active.
When aerobic and muscle-strengthening activities were combined, the effects were additive: risk of all-cause mortality dropped by approximately 40%, cardiovascular mortality by 46%, and cancer mortality by 28%. But the resistance training signal on its own was robust, which is why the WHO’s 2020 Physical Activity Guidelines – for the first time – gave muscle-strengthening activity equal prominence alongside aerobic recommendations.
What the WHO 2020 Guidelines Actually Recommend
The World Health Organization’s 2020 guidelines on physical activity and sedentary behaviour are the most comprehensive update to global exercise recommendations in over a decade. For adults aged 18-64, the guidelines state that individuals “should also do muscle-strengthening activities at moderate or greater intensity that involve all major muscle groups on 2 or more days a week.” For adults over 65, the same core recommendation applies, with the addition of varied multicomponent activities emphasising functional balance and strength on at least 3 days per week specifically to reduce falls risk.
Both recommendations carry the designation “strong recommendation, moderate certainty evidence” – the same classification as the aerobic activity guidelines. This is a meaningful upgrade from earlier versions of the guidelines, which mentioned muscle-strengthening as a supplementary note rather than a core pillar. The change reflects the body of evidence that had accumulated by the early 2020s, including the Momma meta-analysis and a growing set of large prospective studies from the UK Biobank, the European Health Interview Survey, and US National Health Interview Survey cohorts.
The guidelines do not specify what “muscle-strengthening” must look like. Resistance machines, free weights, bodyweight exercises, resistance bands, and load-bearing activities such as heavy gardening or carrying groceries all qualify. The key criteria are moderate or greater intensity, engagement of all major muscle groups (legs, hips, back, abdomen, chest, shoulders, arms), and a frequency of at least twice per week. The threshold to capture most of the mortality benefit is notably accessible: 30 minutes per week split across two sessions represents a meaningful intervention by the evidence standard.
The Sarcopenia Problem – and Why It Matters Beyond the Gym
The mortality data becomes easier to understand when placed alongside the physiology of muscle ageing. Skeletal muscle mass begins declining measurably after age 35, at a rate of roughly 3-8% per decade, accelerating to 25% per decade after age 70. Muscle strength peaks between ages 25 and 35, then begins a slow descent that steepens markedly after 50. The clinical term for this age-related loss is sarcopenia, and a 2022 systematic review and meta-analysis in the Journal of Cachexia, Sarcopenia and Muscle estimated its global prevalence at roughly 10% in adults over 60, rising to 36% in those aged 85-89.
Sarcopenia is not merely a cosmetic or performance issue. Reduced muscle mass is independently associated with higher rates of falls, fractures, insulin resistance, cardiovascular disease, and all-cause mortality. A key mechanism is metabolic: skeletal muscle is the largest site of post-meal glucose disposal in the body, accounting for approximately 80% of insulin-stimulated glucose uptake. When muscle mass declines, glucose disposal capacity falls, peripheral insulin resistance rises, and the downstream metabolic consequences – elevated fasting glucose, higher circulating triglycerides, greater visceral fat accumulation – follow in sequence. This is one reason why resistance training carries independent cardiometabolic benefit that cannot be fully replicated by aerobic training alone.
The public health implication is significant. Population surveys consistently show that muscle-strengthening activity is far less prevalent than aerobic activity. In the United States, National Health Interview Survey data suggests roughly 53% of adults meet aerobic activity guidelines, but only around 23% meet muscle-strengthening guidelines. In the United Kingdom, National Health Service data shows similar patterns. Given the magnitude of the mortality benefit associated with strength training – and the modest time investment required to capture it – this gap represents a substantial missed opportunity in health promotion.
Why Resistance Training Remains Underemphasised in Health Messaging
Several factors explain the gap between what evidence supports and what public health messaging emphasises. The historical narrative around exercise and heart health was built on the aerobic fitness research of the 1960s and 1970s, which established a compelling and well-publicised link between cardiovascular exercise and reduced cardiac mortality. Resistance training research came later and produced findings that were harder to summarise in a simple message – unlike “walk 10,000 steps a day,” there is no single easily marketed prescription for strength training that suits all ages and fitness levels.
There is also a persistent cultural association between resistance training and bodybuilding aesthetics, which alienates a significant proportion of the population – particularly older adults, women, and people who do not identify with gym culture. Yet the research applies equally to all of these groups. Studies specifically examining older adults found that progressive resistance training is one of the most effective interventions available for preserving functional independence, reducing falls risk, and extending healthy life years. These benefits accrue from programmes that look nothing like competitive weightlifting – two sessions per week using bodyweight, resistance bands, or light dumbbells is sufficient to produce meaningful gains in muscle strength and physical function in previously sedentary older adults.
What a Practical Twice-Weekly Programme Looks Like
The WHO guidelines’ requirement to target “all major muscle groups” is the key structural constraint for programme design. In practice this means including exercises that load the lower body (squat-pattern movements, hip hinges, step-ups), the posterior chain (deadlift variations, rows for the back), the pushing muscles (press-ups, overhead press), and the core. A 30-minute session twice per week covering these movement patterns meets the guideline threshold and is compatible with essentially any lifestyle or access level.
Progression matters more than volume. The physiological stimulus for muscle adaptation – both hypertrophic and neuromuscular – requires that the load or difficulty increase gradually over time. This does not require expensive equipment or a personal trainer. Adding one repetition per set, or progressing from a wall press-up to a knee press-up to a full press-up over several weeks, represents the kind of incremental overload that produces genuine adaptation. The Momma meta-analysis found that even the lowest threshold of resistance exercise participation – any regular muscle-strengthening activity compared to none – captured the bulk of the mortality benefit. The marginal return from more sophisticated programming is real but smaller than the initial benefit of simply starting.
Framing Strength as a Health Behaviour, Not a Performance Goal
The shift the evidence demands is largely a framing one. Strength training produces visible physical changes that make it easy to market as a cosmetic or athletic pursuit, and the fitness industry has largely positioned it that way. But the mortality and sarcopenia data position it differently: as a health behaviour with a risk-reduction profile comparable to well-established interventions like blood pressure management and smoking cessation.
A 23% reduction in all-cause mortality, associated with two brief weekly sessions, is not a marginal effect. It is the kind of number that would prompt immediate widespread adoption if it were associated with a pharmaceutical intervention. The WHO’s 2020 decision to elevate muscle-strengthening to an equal footing with aerobic activity in global guidelines reflects this evidence. The challenge now is translating that evidence into the kind of clear, accessible, and widely disseminated public health message that aerobic exercise has benefited from for fifty years.
This article is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting a new exercise programme, particularly if you have an existing health condition.